Targeted gene therapies: tools, applications, optimization

References

• Aarts M, te Riele H. 2011. Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application. Gene Ther 18:213–219.
   PubMed Web of Science ®Google Scholar
• Adams BR, Golding SE, Rao RR, Valerie K. 2010a. Dynamic dependence on ATR and ATM for double-strand break repair in human embryonic stem cells and neural descendants. PLoS ONE 5:e10001.
   PubMedGoogle Scholar
• Adams BR, Hawkins AJ, Povirk LF, Valerie K. 2010b. ATM-independent, high-fidelity nonhomologous end joining predominates in human embryonic stem cells. Aging (Albany NY) 2:582–596.
   PubMedGoogle Scholar
• Alibés A, Serrano L, Nadra AD. 2010. Structure-based DNA-binding prediction and design. Methods Mol Biol 649:77–88.
   PubMedGoogle Scholar
• Alwin S, Gere MB, Guhl E, Effertz K, Barbas CF 3rd, Segal DJ, Weitzman MD, Cathomen T. 2005. Custom zinc-finger nucleases for use in human cells. Mol Ther 12:610–617.
   PubMedGoogle Scholar
• Arcangioli B. 1998. A site- and strand-specific DNA break confers asymmetric switching potential in fission yeast. EMBO J 17: 4503–4510.
   PubMedGoogle Scholar
• Ashworth J, Havranek JJ, Duarte CM, Sussman D, Monnat RJ Jr, Stoddard BL, Baker D. 2006. Computational redesign of endonuclease DNA binding and cleavage specificity. Nature 441:656–659.
   PubMed Web of Science ®Google Scholar
• Aubert M, Ryu BY, Banks L, Rawlings DJ, Scharenberg AM, Jerome KR. 2011. Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI. PLoS ONE 6:e16825.
   PubMed Web of Science ®Google Scholar
• Barrett DM, Zhao Y, Liu X, Jiang S, Carpenito C, Kalos M, Carroll RG, June CH, Grupp SA. 2011. Treatment of advanced leukemia in mice with mRNA engineered T cells. Hum Gene Ther 22:1575–1586.
   PubMed Web of Science ®Google Scholar
• Barzel A, Privman E, Peeri M, Naor A, Shachar E, Burstein D, Lazary R, Gophna U, Pupko T, Kupiec M. 2011. Native homing endonucleases can target conserved genes in humans and in animal models. Nucleic Acids Res 39:6646–6659.
   PubMed Web of Science ®Google Scholar
• Belfort M, Roberts RJ. 1997. Homing endonucleases: keeping the house in order. Nucleic Acids Res 25:3379–3388.
   PubMed Web of Science ®Google Scholar
• Bennardo N, Cheng A, Huang N, Stark JM. 2008. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet 4:e1000110.
   PubMed Web of Science ®Google Scholar
• Bibikova M, Beumer K, Trautman JK, Carroll D. 2003. Enhancing gene targeting with designed zinc finger nucleases. Science 300:764.
   PubMed Web of Science ®Google Scholar
• Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, Chandrasegaran S. 2001. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 21:289–297.
   PubMed Web of Science ®Google Scholar
• Blackburn AC, McLary SC, Naeem R, Luszcz J, Stockton DW, Donehower LA, Mohammed M, Mailhes JB, Soferr T, Naber SP, Otis CN, Jerry DJ. 2004. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Cancer Res 64:5140–5147.
   PubMed Web of Science ®Google Scholar
• Blaese RM, Culver KW, Miller AD, Carter CS, Fleisher T, Clerici M, Shearer G, Chang L, Chiang Y, Tolstoshev P, Greenblatt JJ, Rosenberg SA, Klein H, Berger M, Mullen CA, Ramsey WJ, Muul L, Morgan RA, Anderson WF. 1995. T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science 270:475–480.
   PubMed Web of Science ®Google Scholar
• Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S, Lahaye T, Nickstadt A, Bonas U. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science 326:1509–1512.
   PubMed Web of Science ®Google Scholar
• Bogdanove AJ, Voytas DF. 2011. TAL effectors: customizable proteins for DNA targeting. Science 333:1843–1846.
   PubMed Web of Science ®Google Scholar
• Bouwman P, Aly A, Escandell JM, Pieterse M, Bartkova J, van der Gulden H, Hiddingh S, Thanasoula M, Kulkarni A, Yang Q, Haffty BG, Tommiska J, Blomqvist C, Drapkin R, Adams DJ, Nevanlinna H, Bartek J, Tarsounas M, Ganesan S, Jonkers J. 2010. 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol 17:688–695.
   PubMed Web of Science ®Google Scholar
• Bowden PE. 2011. Gene therapy for keratin genodermatoses: striving forward but obstacles persist. J Invest Dermatol 131:1403–1405.
   PubMedGoogle Scholar
• Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, Roberts JL, Puck JM. 1997. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130:378–387.
   PubMed Web of Science ®Google Scholar
• Bunting SF, Callén E, Wong N, Chen HT, Polato F, Gunn A, Bothmer A, Feldhahn N, Fernandez-Capetillo O, Cao L, Xu X, Deng CX, Finkel T, Nussenzweig M, Stark JM, Nussenzweig A. 2010. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141:243–254.
   PubMed Web of Science ®Google Scholar
• Cannon P, June C. 2011. Chemokine receptor 5 knockout strategies. Curr Opin HIV AIDS 6:74–79.
   PubMed Web of Science ®Google Scholar
• Cermak T, Doyle EL, Christian M, Wang L, Zhang Y, Schmidt C, Baller JA, Somia NV, Bogdanove AJ, Voytas DF. 2011. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting. Nucleic Acids Res 39:e82.
   PubMed Web of Science ®Google Scholar
• Certo MT, Ryu BY, Annis JE, Garibov M, Jarjour J, Rawlings DJ, Scharenberg AM. 2011. Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods 8:671–676.
   PubMedGoogle Scholar
• Chamberlain JR, Deyle DR, Schwarze U, Wang P, Hirata RK, Li Y, Byers PH, Russell DW. 2008. Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta. Mol Ther 16:187–193.
   PubMed Web of Science ®Google Scholar
• Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM, Underwood RA, Song KM, Sussman M, Byers PH, Russell DW. 2004. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198–1201.
   PubMed Web of Science ®Google Scholar
• Chen F, Pruett-Miller SM, Huang Y, Gjoka M, Duda K, Taunton J, Collingwood TN, Frodin M, Davis GD. 2011. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods 8:753–755.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao H. 2005. A highly sensitive selection method for directed evolution of homing endonucleases. Nucleic Acids Res 33:e154.
   PubMedGoogle Scholar
• Chen ZY, He CY, Ehrhardt A, Kay MA. 2003. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8:495–500.
   PubMed Web of Science ®Google Scholar
• Chevalier BS, Stoddard BL. 2001. Homing endonucleases: structural and functional insight into the catalysts of intron/intein mobility. Nucleic Acids Res 29:3757–3774.
   PubMed Web of Science ®Google Scholar
• Chin JY, Kuan JY, Lonkar PS, Krause DS, Seidman MM, Peterson KR, Nielsen PE, Kole R, Glazer PM. 2008. Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids. Proc Natl Acad Sci USA 105:13514–13519.
   PubMed Web of Science ®Google Scholar
• Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF. 2010. Targeting DNA double-strand breaks with TAL effector nucleases. Genetics 186:757–761.
   PubMed Web of Science ®Google Scholar
• Christine CW, Starr PA, Larson PS, Eberling JL, Jagust WJ, Hawkins RA, VanBrocklin HF, Wright JF, Bankiewicz KS, Aminoff MJ. 2009. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology 73:1662–1669.
   PubMed Web of Science ®Google Scholar
• Coleman KA, Greenberg RA. 2011. The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem 286:13669–13680.
   PubMed Web of Science ®Google Scholar
• Colnaghi R, Carpenter G, Volker M, O’Driscoll M. 2011. The consequences of structural genomic alterations in humans: Genomic Disorders, genomic instability and cancer. Semin Cell Dev Biol 22:875–885.
   PubMed Web of Science ®Google Scholar
• Cornu TI, Cathomen T. 2007. Targeted genome modifications using integrase-deficient lentiviral vectors. Mol Ther 15:2107–2113.
   PubMed Web of Science ®Google Scholar
• Cornu TI, Thibodeau-Beganny S, Guhl E, Alwin S, Eichtinger M, Joung JK, Joung JK, Cathomen T. 2008. DNA-binding specificity is a major determinant of the activity and toxicity of zinc-finger nucleases. Mol Ther 16:352–358.
   PubMed Web of Science ®Google Scholar
• Cowell IG, Sunter NJ, Singh PB, Austin CA, Durkacz BW, Tilby MJ. 2007. gammaH2AX foci form preferentially in euchromatin after ionising-radiation. PLoS ONE 2:e1057.
   PubMed Web of Science ®Google Scholar
• Cummings WJ, Bednarski DW, Maizels N. 2008. Genetic variation stimulated by epigenetic modification. PLoS ONE 3:e4075.
   Google Scholar
• Cummings WJ, Yabuki M, Ordinario EC, Bednarski DW, Quay S, Maizels N. 2007. Chromatin structure regulates gene conversion. PLoS Biol 5:e246.
   Google Scholar
• Davis L, Maizels N. 2011. DNA nicks promote efficient and safe targeted gene correction. PLoS ONE 6:e23981.
   Google Scholar
• de Piédoue G, Andrieu-Soler C, Concordet JP, Maurisse R, Sun JS, Lopez B, Kuzniak I, Leboulch P, Feugeas JP. 2007. Targeted gene correction with 5′ acridine-oligonucleotide conjugates. Oligonucleotides 17:258–263.
   PubMed Web of Science ®Google Scholar
• Deem A, Keszthelyi A, Blackgrove T, Vayl A, Coffey B, Mathur R, Chabes A, Malkova A. 2011. Break-induced replication is highly inaccurate. PLoS Biol 9:e1000594.
   PubMed Web of Science ®Google Scholar
• DeKelver RC, Choi VM, Moehle EA, Paschon DE, Hockemeyer D, Meijsing SH, Sancak Y, Cui X, Steine EJ, Miller JC, Tam P, Bartsevich VV, Meng X, Rupniewski I, Gopalan SM, Sun HC, Pitz KJ, Rock JM, Zhang L, Davis GD, Rebar EJ, Cheeseman IM, Yamamoto KR, Sabatini DM, Jaenisch R, Gregory PD, Urnov FD. 2010. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. Genome Res 20:1133–1142.
   PubMed Web of Science ®Google Scholar
• Delacôte F, Perez C, Guyot V, Mikonio C, Potrel P, Cabaniols JP, Delenda C, Pâques F, Duchateau P. 2011. Identification of genes regulating gene targeting by a high-throughput screening approach. J Nucleic Acids 2011: 947212.
   PubMedGoogle Scholar
• Doyon JB, Pattanayak V, Meyer CB, Liu DR. 2006. Directed evolution and substrate specificity profile of homing endonuclease I-SceI. J Am Chem Soc 128:2477–2484.
   PubMed Web of Science ®Google Scholar
• Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, Miller JC, Urnov FD, Gregory PD, Holmes MC. 2011. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods 8:74–79.
   PubMed Web of Science ®Google Scholar
• Elliott B, Richardson C, Winderbaum J, Nickoloff JA, Jasin M. 1998. Gene conversion tracts from double-strand break repair in mammalian cells. Mol Cell Biol 18:93–101.
   PubMed Web of Science ®Google Scholar
• Fan J, Robert C, Jang YY, Liu H, Sharkis S, Baylin SB, Rassool FV. 2011. Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining. Mutat Res 713:8–17.
   PubMed Web of Science ®Google Scholar
• Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 2011. Gene therapy for primary adaptive immune deficiencies. J Allergy Clin Immunol 127:1356–1359.
   PubMedGoogle Scholar
• Fung H, Weinstock DM. 2011. Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells. PLoS ONE 6:e20514.
   Google Scholar
• Gabriel R, Lombardo A, Arens A, Miller JC, Genovese P, Kaeppel C, Nowrouzi A, Bartholomae CC, Wang J, Friedman G, Holmes MC, Gregory PD, Glimm H, Schmidt M, Naldini L, von Kalle C. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat Biotechnol 29:816–823.
   PubMed Web of Science ®Google Scholar
• Gaj T, Mercer AC, Gersbach CA, Gordley RM, Barbas CF 3rd. 2011. Structure-guided reprogramming of serine recombinase DNA sequence specificity. Proc Natl Acad Sci USA 108:498–503.
   PubMedGoogle Scholar
• Gao X, Kim KS, Liu D. 2007. Nonviral gene delivery: what we know and what is next. AAPS J 9:E92–104.
   PubMed Web of Science ®Google Scholar
• Gaspar HB, Cooray S, Gilmour KC, Parsley KL, Zhang F, Adams S, Bjorkegren E, Bayford J, Brown L, Davies EG, Veys P, Fairbanks L, Bordon V, Petropolou T, Kinnon C, Thrasher AJ. 2011. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 3:97ra80.
   PubMed Web of Science ®Google Scholar
• Gersbach CA, Gaj T, Gordley RM, Mercer AC, Barbas CF 3rd. 2011. Targeted plasmid integration into the human genome by an engineered zinc-finger recombinase. Nucleic Acids Res 39:7868–7878.
   PubMedGoogle Scholar
• Ghule PN, Medina R, Lengner CJ, Mandeville M, Qiao M, Dominski Z, Lian JB, Stein JL, van Wijnen AJ, Stein GS. 2011. Reprogramming the pluripotent cell cycle: restoration of an abbreviated G1 phase in human induced pluripotent stem (iPS) cells. J Cell Physiol 226:1149–1156.
   PubMed Web of Science ®Google Scholar
• Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S, Dewell S, Law M, Guo X, Li X, Wen D, Chapgier A, DeKelver RC, Miller JC, Lee YL, Boydston EA, Holmes MC, Gregory PD, Greally JM, Rafii S, Yang C, Scambler PJ, Garrick D, Gibbons RJ, Higgs DR, Cristea IM, Urnov FD, Zheng D, Allis CD. 2010. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678–691.
   PubMed Web of Science ®Google Scholar
• Goodarzi AA, Jeggo P, Lobrich M. 2010. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair (Amst) 9:1273–1282.
   PubMed Web of Science ®Google Scholar
• Grizot S, Smith J, Daboussi F, Prieto J, Redondo P, Merino N, Villate M, Thomas S, Lemaire L, Montoya G, Blanco FJ, Pâques F, Duchateau P. 2009. Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease. Nucleic Acids Res 37:5405–5419.
   PubMedGoogle Scholar
• Grosse S, Huot N, Mahiet C, Arnould S, Barradeau S, Clerre DL, Chion-Sotinel I, Jacqmarcq C, Chapellier B, Ergani A, Desseaux C, Cédrone F, Conseiller E, Pâques F, Labetoulle M, Smith J. 2011. Meganuclease-mediated Inhibition of HSV1 Infection in Cultured Cells. Mol Ther 19:694–702.
   PubMed Web of Science ®Google Scholar
• Guhan N, Muniyappa K. 2003. Structural and functional characteristics of homing endonucleases. Crit Rev Biochem Mol Biol 38:199–248.
   PubMed Web of Science ®Google Scholar
• Guo J, Gaj T, Barbas CF 3rd. 2010. Directed evolution of an enhanced and highly efficient FokI cleavage domain for zinc finger nucleases. J Mol Biol 400:96–107.
   PubMed Web of Science ®Google Scholar
• Gupta A, Meng X, Zhu LJ, Lawson ND, Wolfe SA. 2011. Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases. Nucleic Acids Res 39:381–392.
   PubMedGoogle Scholar
• Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M. 2008. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132–3142.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Hauer J, Lim A, Picard C, Wang GP, Berry CC, Martinache C, Rieux-Laucat F, Latour S, Belohradsky BH, Leiva L, Sorensen R, Debré M, Casanova JL, Blanche S, Durandy A, Bushman FD, Fischer A, Cavazzana-Calvo M. 2010. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 363:355–364.
   PubMed Web of Science ®Google Scholar
• Halford SE, Catto LE, Pernstich C, Rusling DA, Sanders KL. 2011. The reaction mechanism of FokI excludes the possibility of targeting zinc finger nucleases to unique DNA sites. Biochem Soc Trans 39:584–588.
   PubMedGoogle Scholar
• Händel EM, Alwin S, Cathomen T. 2009. Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Mol Ther 17:104–111.
   PubMed Web of Science ®Google Scholar
• Helmink BA, Tubbs AT, Dorsett Y, Bednarski JJ, Walker LM, Feng Z, Sharma GG, McKinnon PJ, Zhang J, Bassing CH, Sleckman BP. 2011. H2AX prevents CtIP-mediated DNA end resection and aberrant repair in G1-phase lymphocytes. Nature 469:245–249.
   PubMed Web of Science ®Google Scholar
• Heyer WD, Ehmsen KT, Liu J. 2010. Regulation of homologous recombination in eukaryotes. Annu Rev Genet 44:113–139.
   PubMed Web of Science ®Google Scholar
• Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, Katibah GE, Amora R, Boydston EA, Zeitler B, Meng X, Miller JC, Zhang L, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R. 2009. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol 27:851–857.
   PubMed Web of Science ®Google Scholar
• Hockemeyer D, Wang H, Kiani S, Lai CS, Gao Q, Cassady JP, Cost GJ, Zhang L, Santiago Y, Miller JC, Zeitler B, Cherone JM, Meng X, Hinkley SJ, Rebar EJ, Gregory PD, Urnov FD, Jaenisch R. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol 29:731–734.
   PubMed Web of Science ®Google Scholar
• Holt N, Wang J, Kim K, Friedman G, Wang X, Taupin V, Crooks GM, Kohn DB, Gregory PD, Holmes MC, Cannon PM. 2010. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat Biotechnol 28:839–847.
   PubMed Web of Science ®Google Scholar
• Hong K, Sherley J, Lauffenburger DA. 2001. Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector. Biomol Eng 18:185–192.
   PubMedGoogle Scholar
• Huertas P, Jackson SP. 2009. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J Biol Chem 284:9558–9565.
   PubMed Web of Science ®Google Scholar
• Jarjour J, West-Foyle H, Certo MT, Hubert CG, Doyle L, Getz MM, Stoddard BL, Scharenberg AM. 2009. High-resolution profiling of homing endonuclease binding and catalytic specificity using yeast surface display. Nucleic Acids Res 37:6871–6880.
   PubMedGoogle Scholar
• Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. 2009. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc Natl Acad Sci USA 106:18786–18791.
   PubMed Web of Science ®Google Scholar
• Kayali R, Bury F, Ballard M, Bertoni C. 2010. Site-directed gene repair of the dystrophin gene mediated by PNA-ssODNs. Hum Mol Genet 19:3266–3281.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee HJ, Kim H, Cho SW, Kim JS. 2009. Targeted genome editing in human cells with zinc finger nucleases constructed via modular assembly. Genome Res 19:1279–1288.
   PubMed Web of Science ®Google Scholar
• Kim JA, Kruhlak M, Dotiwala F, Nussenzweig A, Haber JE. 2007a. Heterochromatin is refractory to gamma-H2AX modification in yeast and mammals. J Cell Biol 178:209–218.
   PubMed Web of Science ®Google Scholar
• Kim KH, Nielsen PE, Glazer PM. 2007b. Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids. Nucleic Acids Res 35:7604–7613.
   PubMed Web of Science ®Google Scholar
• Kim S, Lee MJ, Kim H, Kang M, Kim JS. 2011. Preassembled zinc-finger arrays for rapid construction of ZFNs. Nat Methods 8:7.
   PubMed Web of Science ®Google Scholar
• Kim YG, Cha J, Chandrasegaran S. 1996. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci USA 93:1156–1160.
   PubMed Web of Science ®Google Scholar
• Klug A. 2010. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 79:213–231.
   PubMed Web of Science ®Google Scholar
• Larocque JR, Jasin M. 2010. Mechanisms of recombination between diverged sequences in wild-type and BLM-deficient mouse and human cells. Mol Cell Biol 30:1887–1897.
   PubMedGoogle Scholar
• Larocque JR, Stark JM, Oh J, Bojilova E, Yusa K, Horie K, Takeda J, Jasin M. 2011. Interhomolog recombination and loss of heterozygosity in wild-type and Bloom syndrome helicase (BLM)-deficient mammalian cells. Proc Natl Acad Sci USA 108:11971–11976.
   PubMedGoogle Scholar
• Lee GS, Neiditch MB, Salus SS, Roth DB. 2004. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 117:171–184.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim E, Kim JS. 2010. Targeted chromosomal deletions in human cells using zinc finger nucleases. Genome Res 20:81–89.
   PubMed Web of Science ®Google Scholar
• Li T, Huang S, Zhao X, Wright DA, Carpenter S, Spalding MH, Weeks DP, Yang B. 2011. Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res 39:6315–6325.
   PubMed Web of Science ®Google Scholar
• Limbo O, Chahwan C, Yamada Y, de Bruin RA, Wittenberg C, Russell P. 2007. Ctp1 is a cell-cycle-regulated protein that functions with Mre11 complex to control double-strand break repair by homologous recombination. Mol Cell 28:134–146.
   PubMed Web of Science ®Google Scholar
• Liu J, Majumdar A, Liu J, Thompson LH, Seidman MM. 2010. Sequence conversion by single strand oligonucleotide donors via non-homologous end joining in mammalian cells. J Biol Chem 285:23198–23207.
   PubMed Web of Science ®Google Scholar
• Liu Y, Nairn RS, Vasquez KM. 2009. Targeted gene conversion induced by triplex-directed psoralen interstrand crosslinks in mammalian cells. Nucleic Acids Res 37:6378–6388.
   PubMedGoogle Scholar
• Llorente B, Smith CE, Symington LS. 2008. Break-induced replication: what is it and what is it for? Cell Cycle 7:859–864.
   PubMed Web of Science ®Google Scholar
• Lombardo A, Genovese P, Beausejour CM, Colleoni S, Lee YL, Kim KA, Ando D, Urnov FD, Galli C, Gregory PD, Holmes MC, Naldini L. 2007. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat Biotechnol 25:1298–1306.
   PubMed Web of Science ®Google Scholar
• Lonkar P, Kim KH, Kuan JY, Chin JY, Rogers FA, Knauert MP, Kole R, Nielsen PE, Glazer PM. 2009. Targeted correction of a thalassemia-associated beta-globin mutation induced by pseudo-complementary peptide nucleic acids. Nucleic Acids Res 37:3635–3644.
   Google Scholar
• Lorenz A, Whitby MC. 2006. Crossover promotion and prevention. Biochem Soc Trans 34:537–541.
   PubMedGoogle Scholar
• Lukacsovich T, Yang D, Waldman AS. 1994. Repair of a specific double-strand break generated within a mammalian chromosome by yeast endonuclease I-SceI. Nucleic Acids Res 22:5649–5657.
   PubMed Web of Science ®Google Scholar
• Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, Jiang T, Foley JE, Winfrey RJ, Townsend JA, Unger-Wallace E, Sander JD, Müller-Lerch F, Fu F, Pearlberg J, Göbel C, Dassie JP, Pruett-Miller SM, Porteus MH, Sgroi DC, Iafrate AJ, Dobbs D, McCray PB Jr, Cathomen T, Voytas DF, Joung JK. 2008. Rapid “open-source” engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell 31:294–301.
   PubMed Web of Science ®Google Scholar
• Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell’Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J. 2008. Safety and efficacy of gene transfer for Leber’s congenital amaurosis. N Engl J Med 358:2240–2248.
   PubMed Web of Science ®Google Scholar
• Mahaney BL, Meek K, Lees-Miller SP. 2009. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 417:639–650.
   PubMed Web of Science ®Google Scholar
• Majumdar A, Muniandy PA, Liu J, Liu JL, Liu ST, Cuenoud B, Seidman MM. 2008. Targeted gene knock in and sequence modulation mediated by a psoralen-linked triplex-forming oligonucleotide. J Biol Chem 283:11244–11252.
   PubMedGoogle Scholar
• Malone RW, Felgner PL, Verma IM. 1989. Cationic liposome-mediated RNA transfection. Proc Natl Acad Sci USA 86:6077–6081.
   PubMed Web of Science ®Google Scholar
• Manno CS, Pierce GF, Arruda VR, Glader B, Ragni M, Rasko JJ, Rasko J, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Rustagi PK, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA. 2006. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342–347.
   PubMed Web of Science ®Google Scholar
• Mátrai J, Chuah MK, VandenDriessche T. 2010. Recent advances in lentiviral vector development and applications. Mol Ther 18:477–490.
   PubMed Web of Science ®Google Scholar
• McConnell Smith A, Takeuchi R, Pellenz S, Davis L, Maizels N, Monnat RJ Jr, Stoddard BL. 2009. Generation of a nicking enzyme that stimulates site-specific gene conversion from the I-AniI LAGLIDADG homing endonuclease. Proc Natl Acad Sci USA 106:5099–5104.
   PubMed Web of Science ®Google Scholar
• McCord RA, Michishita E, Hong T, Berber E, Boxer LD, Kusumoto R, Guan S, Shi X, Gozani O, Burlingame AL, Bohr VA, Chua KF. 2009. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 1:109–121.
   PubMedGoogle Scholar
• Mehnert JM, Kelly WK. 2007. Histone deacetylase inhibitors: biology and mechanism of action. Cancer J 13:23–29.
   PubMed Web of Science ®Google Scholar
• Mendell JR, Campbell K, Rodino-Klapac L, Sahenk Z, Shilling C, Lewis S, Bowles D, Gray S, Li C, Galloway G, Malik V, Coley B, Clark KR, Li J, Xiao X, Samulski J, McPhee SW, Samulski RJ, Walker CM. 2010. Dystrophin immunity in Duchenne’s muscular dystrophy. N Engl J Med 363:1429–1437.
   PubMed Web of Science ®Google Scholar
• Metzger MJ, McConnell-Smith A, Stoddard BL, Miller AD. 2011. ingle-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template. Nucleic Acids Res 39:926–935.
   PubMedGoogle Scholar
• Miller JC, Holmes MC, Wang J, Guschin DY, Lee YL, Rupniewski I, Beausejour CM, Waite AJ, Wang NS, Kim KA, Gregory PD, Pabo CO, Rebar EJ. 2007. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat Biotechnol 25:778–785.
   PubMed Web of Science ®Google Scholar
• Miller KM, Tjeertes JV, Coates J, Legube G, Polo SE, Britton S, Jackson SP. 2010. Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining. Nat Struct Mol Biol 17:1144–1151.
   PubMed Web of Science ®Google Scholar
• Mitchell AM, Nicolson SC, Warischalk JK, Samulski RJ. 2010. AAV’s anatomy: roadmap for optimizing vectors for translational success. Curr Gene Ther 10:319–340.
   PubMed Web of Science ®Google Scholar
• Mladenov E, Iliakis G. 2011. Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways. Mutat Res 711:61–72.
   PubMed Web of Science ®Google Scholar
• Moehle EA, Moehle EA, Rock JM, Rock JM, Lee YL, Lee YL, Jouvenot Y, Jouvenot Y, DeKelver RC, Dekelver RC, Gregory PD, Gregory PD, Urnov FD, Urnov FD, Holmes MC, Holmes MC. 2007. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 104:3055–3060.
   PubMed Web of Science ®Google Scholar
• Moore MJ, Flotte TR. 2010. Autoimmunity in a genetic disease – a cautionary tale. N Engl J Med 363:1473–1475.
   PubMedGoogle Scholar
• Morbitzer R, Elsaesser J, Hausner J, Lahaye T. 2011. Assembly of custom TALE-type DNA binding domains by modular cloning. Nucleic Acids Res 39:5790–5799.
   PubMed Web of Science ®Google Scholar
• Moscou MJ, Bogdanove AJ. 2009. A simple cipher governs DNA recognition by TAL effectors. Science 326:1501.
   PubMed Web of Science ®Google Scholar
• Moynahan ME, Jasin M. 2010. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 11:196–207.
   PubMed Web of Science ®Google Scholar
• Mukherjee A, Vasquez KM. 2011. Triplex technology in studies of DNA damage, DNA repair, and mutagenesis. Biochimie 93:1197–1208.
   PubMedGoogle Scholar
• Mussolino C, Morbitzer R, Lütge F, Dannemann N, Lahaye T, Cathomen T. 2011. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Nucleic Acids Res 39:9283–9293.
   PubMed Web of Science ®Google Scholar
• Nagaraju G, Hartlerode A, Kwok A, Chandramouly G, Scully R. 2009. XRCC2 and XRCC3 regulate the balance between short- and long-tract gene conversions between sister chromatids. Mol Cell Biol 29:4283–4294.
   PubMed Web of Science ®Google Scholar
• Nagaraju G, Odate S, Xie A, Scully R. 2006. Differential regulation of short- and long-tract gene conversion between sister chromatids by Rad51C. Mol Cell Biol 26:8075–8086.
   PubMed Web of Science ®Google Scholar
• Narsinh KH, Wu JC. 2010. Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead. Mol Ther 18:1061–1063.
   PubMed Web of Science ®Google Scholar
• Nickoloff JA, Chen EY, Heffron F. 1986. A 24-base-pair DNA sequence from the MAT locus stimulates intergenic recombination in yeast. Proc Natl Acad Sci USA 83:7831–7835.
   PubMedGoogle Scholar
• Nimonkar AV, Genschel J, Kinoshita E, Polaczek P, Campbell JL, Wyman C, Modrich P, Kowalczykowski SC. 2011. BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev 25:350–362.
   PubMed Web of Science ®Google Scholar
• Niu Y, Tenney K, Li H, Gimble FS. 2008. Engineering variants of the I-SceI homing endonuclease with strand-specific and site-specific DNA-nicking activity. J Mol Biol 382:188–202.
   PubMedGoogle Scholar
• Nussenzweig A, Nussenzweig MC. 2010. Origin of chromosomal translocations in lymphoid cancer. Cell 141:27–38.
   PubMed Web of Science ®Google Scholar
• O’Keefe C, McDevitt MA, Maciejewski JP. 2010. Copy neutral loss of heterozygosity: a novel chromosomal lesion in myeloid malignancies. Blood 115:2731–2739.
   PubMed Web of Science ®Google Scholar
• Odersky A, Panyutin IV, Panyutin IG, Schunck C, Feldmann E, Goedecke W, Neumann RD, Obe G, Pfeiffer P. 2002. Repair of sequence-specific 125I-induced double-strand breaks by nonhomologous DNA end joining in mammalian cell-free extracts. J Biol Chem 277:11756–11764.
   PubMedGoogle Scholar
• Okada T, Uchibori R, Iwata-Okada M, Takahashi M, Nomoto T, Nonaka-Sarukawa M, Ito T, Liu Y, Mizukami H, Kume A, Kobayashi E, Ozawa K. 2006. A histone deacetylase inhibitor enhances recombinant adeno-associated virus-mediated gene expression in tumor cells. Mol Ther 13:738–746.
   PubMed Web of Science ®Google Scholar
• Ordinario EC, Yabuki M, Handa P, Cummings WJ, Maizels N. 2009. RAD51 paralogs promote homology-directed repair at diversifying immunoglobulin V regions. BMC Mol Biol 10:98.
   PubMedGoogle Scholar
• Papapetrou EP, Lee G, Malani N, Setty M, Riviere I, Tirunagari LM, Kadota K, Roth SL, Giardina P, Viale A, Leslie C, Bushman FD, Studer L, Sadelain M. 2011. Genomic safe harbors permit high ß-globin transgene expression in thalassemia induced pluripotent stem cells. Nat Biotechnol 29:73–78.
   PubMed Web of Science ®Google Scholar
• Pattanayak V, Ramirez CL, Joung JK, Liu DR. 2011. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat Methods 8:765–770.
   PubMed Web of Science ®Google Scholar
• Perez EE, Wang J, Miller JC, Jouvenot Y, Kim KA, Liu O, Wang N, Lee G, Bartsevich VV, Lee YL, Guschin DY, Rupniewski I, Waite AJ, Carpenito C, Carroll RG, Orange JS, Urnov FD, Rebar EJ, Ando D, Gregory PD, Riley JL, Holmes MC, June CH. 2008. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases. Nat Biotechnol 26:808–816.
   PubMed Web of Science ®Google Scholar
• Petek LM, Russell DW, Miller DG. 2010. Frequent endonuclease cleavage at off-target locations in vivo. Mol Ther 18:983–986.
   PubMedGoogle Scholar
• Pichavant C, Aartsma-Rus A, Clemens PR, Davies KE, Dickson G, Takeda S, Wilton SD, Wolff JA, Wooddell CI, Xiao X, Tremblay JP. 2011. Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther 19:830–840.
   PubMed Web of Science ®Google Scholar
• Plessis A, Perrin A, Haber JE, Dujon B. 1992. Site-specific recombination determined by I-SceI, a mitochondrial group I intron-encoded endonuclease expressed in the yeast nucleus. Genetics 130:451–460.
   PubMedGoogle Scholar
• Polo SE, Jackson SP. 2011. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 25:409–433.
   PubMed Web of Science ®Google Scholar
• Porteus MH. 2006. Mammalian gene targeting with designed zinc finger nucleases. Mol Ther 13:438–446.
   PubMed Web of Science ®Google Scholar
• Porteus MH, Baltimore D. 2003. Chimeric nucleases stimulate gene targeting in human cells. Science 300:763.
   PubMed Web of Science ®Google Scholar
• Porteus MH, Carroll D. 2005. Gene targeting using zinc finger nucleases. Nat Biotechnol 23:967–973.
   PubMed Web of Science ®Google Scholar
• Porteus MH, Cathomen T, Weitzman MD, Baltimore D. 2003. Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol Cell Biol 23:3558–3565.
   PubMed Web of Science ®Google Scholar
• Pruett-Miller SM, Connelly JP, Maeder ML, Joung JK, Porteus MH. 2008. Comparison of zinc finger nucleases for use in gene targeting in mammalian cells. Mol Ther 16:707–717.
   PubMed Web of Science ®Google Scholar
• Pruett-Miller SM, Reading DW, Porter SN, Porteus MH. 2009. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet 5:e1000376.
   PubMed Web of Science ®Google Scholar
• Puchta H, Dujon B, Hohn B. 1993. Homologous recombination in plant cells is enhanced by in vivo induction of double strand breaks into DNA by a site-specific endonuclease. Nucleic Acids Res 21:5034–5040.
   PubMed Web of Science ®Google Scholar
• Raab JR, Kamakaka RT. 2010. Insulators and promoters: closer than we think. Nat Rev Genet 11:439–446.
   PubMed Web of Science ®Google Scholar
• Radecke F, Peter I, Radecke S, Gellhaus K, Schwarz K, Cathomen T. 2006. Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break. Mol Ther 14:798–808.
   PubMed Web of Science ®Google Scholar
• Radecke S, Radecke F, Cathomen T, Schwarz K. 2010. Zinc-finger nuclease-induced gene repair with oligodeoxynucleotides: wanted and unwanted target locus modifications. Mol Ther 18:743–753.
   PubMed Web of Science ®Google Scholar
• Rahman SH, Maeder ML, Joung JK, Cathomen T. 2011. Zinc-finger nucleases for somatic gene therapy: the next frontier. Hum Gene Ther 22:925–933.
   PubMed Web of Science ®Google Scholar
• Ramalingam S, Kandavelou K, Rajenderan R, Chandrasegaran S. 2011. Creating designed zinc-finger nucleases with minimal cytotoxicity. J Mol Biol 405:630–641.
   PubMedGoogle Scholar
• Redondo P, Prieto J, Muñoz IG, Alibés A, Stricher F, Serrano L, Cabaniols JP, Daboussi F, Arnould S, Perez C, Duchateau P, Pâques F, Blanco FJ, Montoya G. 2008. Molecular basis of xeroderma pigmentosum group C DNA recognition by engineered meganucleases. Nature 456:107–111.
   PubMed Web of Science ®Google Scholar
• Reeves R, Gorman CM, Howard B. 1985. Minichromosome assembly of non-integrated plasmid DNA transfected into mammalian cells. Nucleic Acids Res 13:3599–3615.
   PubMed Web of Science ®Google Scholar
• Rouet P, Smih F, Jasin M. 1994a. Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. Proc Natl Acad Sci USA 91:6064–6068.
   PubMed Web of Science ®Google Scholar
• Rouet P, Smih F, Jasin M. 1994b. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol Cell Biol 14:8096–8106.
   PubMed Web of Science ®Google Scholar
• Russell DW, Hirata RK. 1998. Human gene targeting by viral vectors. Nat Genet 18:325–330.
   PubMed Web of Science ®Google Scholar
• Sander JD, Maeder ML, Joung JK. 2011. Engineering designer nucleases with customized cleavage specificities. Curr Protoc Mol Biol Chapter 12: Unit12.13.
   PubMedGoogle Scholar
• Sanders KL, Catto LE, Bellamy SR, Halford SE. 2009. Targeting individual subunits of the FokI restriction endonuclease to specific DNA strands. Nucleic Acids Res 37:2105–2115.
   PubMedGoogle Scholar
• Sartori AA, Lukas C, Coates J, Mistrik M, Fu S, Bartek J, Baer R, Lukas J, Jackson SP. 2007. Human CtIP promotes DNA end resection. Nature 450:509–514.
   PubMed Web of Science ®Google Scholar
• Scalley-Kim M, McConnell-Smith A, Stoddard BL. 2007. Coevolution of a homing endonuclease and its host target sequence. J Mol Biol 372:1305–1319.
   PubMed Web of Science ®Google Scholar
• Shaw KL, Kohn DB. 2011. A tale of two SCIDs. Sci Transl Med 3:97ps36.
   PubMedGoogle Scholar
• Simsek D, Brunet E, Wong SY, Katyal S, Gao Y, McKinnon PJ, Lou J, Zhang L, Li J, Rebar EJ, Gregory PD, Holmes MC, Jasin M. 2011. DNA ligase III promotes alternative nonhomologous end-joining during chromosomal translocation formation. PLoS Genet 7:e1002080.
   PubMed Web of Science ®Google Scholar
• Simsek D, Jasin M. 2010. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol 17:410–416.
   PubMed Web of Science ®Google Scholar
• Smith CE, Llorente B, Symington LS. 2007. Template switching during break-induced replication. Nature 447:102–105.
   PubMed Web of Science ®Google Scholar
• Soldner F, Laganière J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, Khurana V, Golbe LI, Myers RH, Lindquist S, Zhang L, Guschin D, Fong LK, Vu BJ, Meng X, Urnov FD, Rebar EJ, Gregory PD, Zhang HS, Jaenisch R. 2011. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146:318–331.
   PubMed Web of Science ®Google Scholar
• Söllü C, Pars K, Cornu TI, Thibodeau-Beganny S, Maeder ML, Joung JK, Heilbronn R, Cathomen T. 2010. Autonomous zinc-finger nuclease pairs for targeted chromosomal deletion. Nucleic Acids Res 38:8269–8276.
   PubMed Web of Science ®Google Scholar
• Soutoglou E, Misteli T. 2008. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 320:1507–1510.
   PubMed Web of Science ®Google Scholar
• Stein S, Ott MG, Schultze-Strasser S, Jauch A, Burwinkel B, Kinner A, Schmidt M, Krämer A, Schwäble J, Glimm H, Koehl U, Preiss C, Ball C, Martin H, Göhring G, Schwarzwaelder K, Hofmann WK, Karakaya K, Tchatchou S, Yang R, Reinecke P, Kühlcke K, Schlegelberger B, Thrasher AJ, Hoelzer D, Seger R, von Kalle C, Grez M. 2010. Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16:198–204.
   PubMed Web of Science ®Google Scholar
• Storici F, Durham CL, Gordenin DA, Resnick MA. 2003. Chromosomal site-specific double-strand breaks are efficiently targeted for repair by oligonucleotides in yeast. Proc Natl Acad Sci USA 100:14994–14999.
   PubMed Web of Science ®Google Scholar
• Strathern JN, Weinstock KG, Higgins DR, McGill CB. 1991. A novel recombinator in yeast based on gene II protein from bacteriophage f1. Genetics 127:61–73.
   PubMedGoogle Scholar
• Symington LS, Gautier J. 2011. Double-strand break end resection and repair pathway choice. Annu Rev Genet 45:247–271.
   PubMed Web of Science ®Google Scholar
• Szczepek M, Brondani V, Büchel J, Serrano L, Segal DJ, Cathomen T. 2007. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 25:786–793.
   PubMed Web of Science ®Google Scholar
• Szeto MD, Boissel SJ, Baker D, Thyme SB. 2011. Mining endonuclease cleavage determinants in genomic sequence data. J Biol Chem 286:32617–32627.
   PubMedGoogle Scholar
• Taghian DG, Nickoloff JA. 1997. Chromosomal double-strand breaks induce gene conversion at high frequency in mammalian cells. Mol Cell Biol 17:6386–6393.
   PubMed Web of Science ®Google Scholar
• Takeuchi R, Lambert AR, Mak AN, Jacoby K, Dickson RJ, Gloor GB, Scharenberg AM, Edgell DR, Stoddard BL. 2011. Tapping natural reservoirs of homing endonucleases for targeted gene modification. Proc Natl Acad Sci USA 108:13077–13082.
   PubMed Web of Science ®Google Scholar
• Thompson SL, Compton DA. 2011. Chromosomes and cancer cells. Chromosome Res 19:433–444.
   PubMedGoogle Scholar
• Thyme SB, Jarjour J, Takeuchi R, Havranek JJ, Ashworth J, Scharenberg AM, Stoddard BL, Baker D. 2009. Exploitation of binding energy for catalysis and design. Nature 461:1300–1304.
   PubMedGoogle Scholar
• Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646–651.
   PubMed Web of Science ®Google Scholar
• Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. 2010. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 11:636–646.
   PubMed Web of Science ®Google Scholar
• Van Tendeloo VF, Ponsaerts P, Lardon F, Nijs G, Lenjou M, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN. 2001. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49–56.
   PubMed Web of Science ®Google Scholar
• Wang H, Perrault AR, Takeda Y, Qin W, Wang H, Iliakis G. 2003. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 31:5377–5388.
   PubMedGoogle Scholar
• Wanisch K, Yáñez-Muñoz RJ. 2009. Integration-deficient lentiviral vectors: a slow coming of age. Mol Ther 17:1316–1332.
   PubMed Web of Science ®Google Scholar
• Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. 2010. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7:618–630.
   PubMed Web of Science ®Google Scholar
• Yabuki M, Ordinario EC, Cummings WJ, Fujii MM, Maizels N. 2009. E2A acts in cis in G1 phase of cell cycle to promote Ig gene diversification. J Immunol 182:408–415.
   PubMedGoogle Scholar
• Yáñez-Muñoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, Buch P, MacLaren RE, Anderson PN, Barker SE, Duran Y, Bartholomae C, von Kalle C, Heckenlively JR, Kinnon C, Ali RR, Thrasher AJ. 2006. Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12:348–353.
   PubMed Web of Science ®Google Scholar
• Yannaki E, Emery DW, Stamatoyannopoulos G. 2010. Gene therapy for ß-thalassaemia: the continuing challenge. Expert Rev Mol Med 12:e31.
   PubMed Web of Science ®Google Scholar
• Yun MH, Hiom K. 2009. CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 459:460–463.
   PubMed Web of Science ®Google Scholar
• Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. 2011. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 29:149–153.
   PubMed Web of Science ®Google Scholar
• Zhao N, Fogg JM, Zechiedrich L, Zu Y. 2011. Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells. Gene Ther 18:220–224.
   PubMed Web of Science ®Google Scholar
• Zou J, Maeder ML, Mali P, Pruett-Miller SM, Thibodeau-Beganny S, Chou BK, Chen G, Ye Z, Park IH, Daley GQ, Porteus MH, Joung JK, Cheng L. 2009. Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. Cell Stem Cell 5:97–110.
   PubMed Web of Science ®Google Scholar